Career Opportunities in Drug Regulatory Authority of Pakistan

Career Opportunities in Drug Regulatory Authority of Pakistan – Drug Regulatory Authority of Pakistan Skip to content Drug Regulatory Authority of Pakistan Ministry of National Health Services, Regulations & Coordination اردو | English facebook-square x envelope Menu About Us DRAP at a Glance Organization Executive Management Legislation Boards and Committees Quality Management System Therapeutic Goods Drugs Medical Devices Alternative Medicine Controlled Substances Emergency Use Authorizations Clinical Trials Oversight Licensing and Inspections Quality Controls Labs Import & Export Advertisement Approvals Safety Info Product Recalls Safety Communication Safety Reporting News & Updates Regulatory Updates Press Releases Careers Tenders Events Publications Essential Medicine Lists Guidelines Newsletters Regulatory Procedures Regulatory Fees Application Forms Public Consultation Minutes of the Meetings E-Services Medicine Availability Public Medicine Shortage Reporting Hospital Medicine Shortage Reporting Focal Person Nomination Support Facilitation Desk Complaints Contact Us Home > News & Updates > Careers > Career Opportunities in Drug Regulatory Authority of Pakistan Career Opportunities in Drug Regulatory Authority of Pakistan Yasir Mahmood Careers May 1, 2026 May 18, 2026 Applications are invited from citizens of Pakistan fulfilling the given conditions for appointment against the following positions in the Drug Regulatory Authority of Pakistan (DRAP). The details of requisite qualification, experience, age limit and regional/provincial quota and application procedure are given in following document:- (Syllabus is also given at the end) 54×4 Ad 30-04-26 Download Syllabus: Syllabus DDs ADs Download Share this: Share on LinkedIn (Opens in new window) LinkedIn Share on WhatsApp (Opens in new window) WhatsApp Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X ← Directive on the security of online portals and engagement with authorized personnel/consultants 25. Recall Alert (Human) – CDL Declared Substandard products. → Quick Navigation Quick Navigation Select Category About Us Legislation Notifications SROs COVID-19 News & Updates Careers Events Press Releases Regulatory Updates Advertisements Alternative Medicines Clinical Trials Controlled Substances Drugs General Licensing and Inspections Medical Devices Pharmacovigilance Tenders Publications Invitation for Comments Meeting Minutes Central Licensing Board Clinical Studies Committee Enlistment Evaluation Committee Medical Devices Board Pharmacovigilance RAE Committee Registration Board Safety Info Product Recalls Recall Alerts Safety Communication Health Professional Alerts Safety Alerts Uncategorized Registered Drugs Index Drug Pricing Index List of Pharmaceutical Units Archives Archives Select Month October 2026 (17) September 2026 (27) August 2026 (7) July 2026 (16) June 2026 (10) May 2026 (19) April 2026 (11) March 2026 (21) February 2026 (13) January 2026 (20) December 2025 (21) November 2025 (21) October 2025 (36) September 2025 (32) August 2025 (14) July 2025 (24) June 2025 (22) May 2025 (15) April 2025 (24) March 2025 (17) February 2025 (15) January 2025 (21) December 2024 (9) November 2024 (19) October 2024 (19) September 2024 (14) August 2024 (6) July 2024 (8) June 2024 (7) May 2024 (17) April 2024 (16) March 2024 (10) February 2024 (19) January 2024 (13) December 2023 (13) November 2023 (8) October 2023 (17) September 2023 (16) August 2023 (12) July 2023 (12) June 2023 (12) May 2023 (14) April 2023 (14) March 2023 (14) February 2023 (17) January 2023 (14) December 2022 (13) November 2022 (25) October 2022 (17) September 2022 (13) August 2022 (10) July 2022 (12) June 2022 (11) May 2022 (11) April 2022 (15) March 2022 (9) February 2022 (19) January 2022 (3) December 2021 (12) November 2021 (12) October 2021 (16) September 2021 (9) August 2021 (8) July 2021 (8) June 2021 (5) April 2021 (2) March 2021 (3) February 2021 (8) January 2021 (